Research Article

Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms

Table 3

Univariate and multivariate Cox analyses in RCC patients with BM.

Univariate Cox analysisMultivariate Cox analysis
HR95% CIHR95% CI

Age
 <65
 ≥651.0260.7981.3190.844

Race
 Black
 Others1.6600.9133.0200.097
 White1.2930.8272.0230.260

Sex
 Female
 Male1.1090.8471.4520.451

Grade
 I-II
 III-IV1.4111.0741.8530.0131.6691.2352.257≤0.001

T stage
 T1-2
 T3-41.3881.0801.7850.010

Laterality
 Left
 Right1.0990.8641.3970.443

Histologic type
 CP
 CC0.8480.5371.3390.4790.7060.4401.1320.148
 CD1.1570.4872.7460.7420.7230.3001.7430.471
 PL2.7671.1676.5570.0212.4921.0365.9940.041
Tumor size, cm
 <4
 4–71.1250.6831.8510.644
 >71.3230.8212.1320.250

N stage
 N0
 N11.7911.3782.328≤0.0011.3881.0491.8380.022

Surgery
 No
 Yes0.4160.3130.552≤0.0010.3940.2840.546≤0.001

Radiotherapy
 No
 Yes1.1030.8621.4110.438

Chemotherapy
 No
 Yes1.4631.1281.8980.004

Brain metastasis
 No
 Yes2.3151.5753.403≤0.0011.8011.2012.7000.004

Liver metastasis
 No
 Yes1.9601.3492.847≤0.001

Lung metastasis
 No
 Yes2.2611.7712.887≤0.0011.7451.3422.269≤0.001

Insurance status
 No
 Yes1.2270.6282.3960.549

Marital status
 No
 Yes0.9940.7681.2860.961

BM, bone metastasis; RCC, renal cell carcinoma; CP, chromophobe; CC, clear cell; CD, collecting duct; PL, papillary.